Estimation of the Impulse Response of the AWGN Channel with ISI within an Iterative Equalization and Decoding System That Uses LDPC Codes.

In this paper, new schemes have been proposed for the estimation of the additive white Gaussian noise (AWGN) channel with intersymbol interference (ISI) in an iterative equalization and decoding system using low-density parity check (LDPC) codes. This article explores the use of the least squares algorithm in various scenarios. For example, the impulse response of the AWGN channel h was initially estimated using a training sequence.

Performance Analysis of Turbo Codes, LDPC Codes, and Polar Codes over an AWGN Channel in the Presence of Inter Symbol Interference.

This paper discusses the results of simulations relating to the performances of turbo codes, low density parity check (LDPC) codes, and polar codes over an additive white Gaussian noise (AWGN) channel in the presence of inter symbol interference, denoting the disturbances that altered the original signal. To eliminate the negative effects of inter symbol interference (ISI), an equalizer was used at the level of the receiver. Practically, two types of equalizers were used: zero forcing (ZF) and minimum mean square error (MMSE), considering the case of perfect channel estimation and the case of estimation using the least square algorithm.

Current Role of Delta Radiomics in Head and Neck Oncology.

The latest developments in the management of head and neck cancer show an increasing trend in the implementation of novel approaches using artificial intelligence for better patient stratification and treatment-related risk evaluation. Radiomics, or the extraction of data from various imaging modalities, is a tool often used to evaluate specific features related to the tumour or normal tissue that are not identifiable by the naked eye and which can add value to existing clinical data. Furthermore, the assessment of feature variations from one time point to another based on subsequent images, known as delta radiomics, was shown to have even higher value for treatment-outcome prediction or patient stratification into risk categories.